130 related articles for article (PubMed ID: 9327883)
1. Dopamine transporter changes in neuropsychiatric disorders.
Wong DF; Ricaurte G; Gründer G; Rothman R; Naidu S; Singer H; Harris J; Yokoi F; Villemagne V; Szymanski S; Gjedde A; Kuhar M
Adv Pharmacol; 1998; 42():219-23. PubMed ID: 9327883
[No Abstract] [Full Text] [Related]
2. Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo.
Wong DF; Harris JC; Naidu S; Yokoi F; Marenco S; Dannals RF; Ravert HT; Yaster M; Evans A; Rousset O; Bryan RN; Gjedde A; Kuhar MJ; Breese GR
Proc Natl Acad Sci U S A; 1996 May; 93(11):5539-43. PubMed ID: 8643611
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography radioligands for dopamine transporters and studies in human and nonhuman primates.
Volkow ND; Fowler JS; Ding YS; Wang GJ; Gatley SJ
Adv Pharmacol; 1998; 42():211-4. PubMed ID: 9327881
[No Abstract] [Full Text] [Related]
4. Single photon emission computed tomography imaging of dopaminergic function: presynaptic transporter, postsynaptic receptor, and "intrasynaptic" transmitter.
Innis RB
Adv Pharmacol; 1998; 42():215-9. PubMed ID: 9327882
[No Abstract] [Full Text] [Related]
5. Evaluation of [11C]RTI-121 as a selective radioligand for PET studies of the dopamine transporter.
Hume SP; Luthra SK; Brown DJ; Opacka-Juffry J; Osman S; Ashworth S; Myers R; Brady F; Carroll FI; Kuhar MJ; Brooks DJ
Nucl Med Biol; 1996 Apr; 23(3):377-84. PubMed ID: 8782251
[TBL] [Abstract][Full Text] [Related]
6. [123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder.
Malison RT; McDougle CJ; van Dyck CH; Scahill L; Baldwin RM; Seibyl JP; Price LH; Leckman JF; Innis RB
Am J Psychiatry; 1995 Sep; 152(9):1359-61. PubMed ID: 7653693
[TBL] [Abstract][Full Text] [Related]
7. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.
Volkow ND; Chang L; Wang GJ; Fowler JS; Leonido-Yee M; Franceschi D; Sedler MJ; Gatley SJ; Hitzemann R; Ding YS; Logan J; Wong C; Miller EN
Am J Psychiatry; 2001 Mar; 158(3):377-82. PubMed ID: 11229977
[TBL] [Abstract][Full Text] [Related]
8. Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations.
Villemagne V; Yuan J; Wong DF; Dannals RF; Hatzidimitriou G; Mathews WB; Ravert HT; Musachio J; McCann UD; Ricaurte GA
J Neurosci; 1998 Jan; 18(1):419-27. PubMed ID: 9412518
[TBL] [Abstract][Full Text] [Related]
9. 3 alpha-(4'-substituted phenyl)tropane-2 beta-carboxylic acid methyl esters: novel ligands with high affinity and selectivity at the dopamine transporter.
Holmquist CR; Keverline-Frantz KI; Abraham P; Boja JW; Kuhar MJ; Carroll FI
J Med Chem; 1996 Oct; 39(21):4139-41. PubMed ID: 8863789
[No Abstract] [Full Text] [Related]
10. Presynaptic and postsynaptic dopaminergic binding densities in the nigrostriatal and mesocortical systems in early Parkinson's disease: a double-tracer positron emission tomography study.
Ouchi Y; Kanno T; Okada H; Yoshikawa E; Futatsubashi M; Nobezawa S; Torizuka T; Sakamoto M
Ann Neurol; 1999 Nov; 46(5):723-31. PubMed ID: 10553989
[TBL] [Abstract][Full Text] [Related]
11. Model for estimating dopamine transporter occupancy and subsequent increases in synaptic dopamine using positron emission tomography and carbon-11-labeled cocaine.
Gatley SJ; Volkow ND; Gifford AN; Ding YS; Logan J; Wang GJ
Biochem Pharmacol; 1997 Jan; 53(1):43-52. PubMed ID: 8960062
[TBL] [Abstract][Full Text] [Related]
12. Ketamine decreased striatal [(11)C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: multiparametric PET studies combined with microdialysis analysis.
Tsukada H; Harada N; Nishiyama S; Ohba H; Sato K; Fukumoto D; Kakiuchi T
Synapse; 2000 Aug; 37(2):95-103. PubMed ID: 10881030
[TBL] [Abstract][Full Text] [Related]
13. Development of imaging agents for the dopamine transporter.
Carroll FI; Scheffel U; Dannals RF; Boja JW; Kuhar MJ
Med Res Rev; 1995 Sep; 15(5):419-44. PubMed ID: 8531503
[No Abstract] [Full Text] [Related]
14. [18F]CFT ([18F]WIN 35,428), a radioligand to study the dopamine transporter with PET: biodistribution in rats.
Haaparanta M; Bergman J; Laakso A; Hietala J; Solin O
Synapse; 1996 Aug; 23(4):321-7. PubMed ID: 8855517
[TBL] [Abstract][Full Text] [Related]
15. [123I]beta-CIT SPECT imaging of dopamine transporter availability after mazindol administration in human cocaine addicts.
Malison RT; McCance E; Carpenter LL; Baldwin RM; Seibyl JP; Price LH; Kosten TR; Innis RB
Psychopharmacology (Berl); 1998 Jun; 137(4):321-5. PubMed ID: 9676890
[TBL] [Abstract][Full Text] [Related]
16. Relationship between subjective effects of cocaine and dopamine transporter occupancy.
Volkow ND; Wang GJ; Fischman MW; Foltin RW; Fowler JS; Abumrad NN; Vitkun S; Logan J; Gatley SJ; Pappas N; Hitzemann R; Shea CE
Nature; 1997 Apr; 386(6627):827-30. PubMed ID: 9126740
[TBL] [Abstract][Full Text] [Related]
17. [(11)C, (127)I] Altropane: a highly selective ligand for PET imaging of dopamine transporter sites.
Fischman AJ; Bonab AA; Babich JW; Livni E; Alpert NM; Meltzer PC; Madras BK
Synapse; 2001 Mar; 39(4):332-42. PubMed ID: 11169784
[TBL] [Abstract][Full Text] [Related]
18. Euphorigenic doses of cocaine reduce [123I]beta-CIT SPECT measures of dopamine transporter availability in human cocaine addicts.
Malison RT; Best SE; Wallace EA; McCance E; Laruelle M; Zoghbi SS; Baldwin RM; Seibyl JS; Hoffer PB; Price LH
Psychopharmacology (Berl); 1995 Dec; 122(4):358-62. PubMed ID: 8657833
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of 3beta-(4-[18F]fluoromethylphenyl)- and 3beta-(2-[18F] fluoromethylphenyl)tropane-2beta-carboxylic acid methyl esters: new ligands for mapping brain dopamine transporter with positron emission tomography.
Petric A; Barrio JR; Namavari M; Huang SC; Satyamurthy N
Nucl Med Biol; 1999 Jul; 26(5):529-35. PubMed ID: 10473191
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of a series of novel N- or O-fluoroalkyl derivatives of tropane: potential positron emission tomography (PET) imaging agents for the dopamine transporter.
Gu XH; Zong R; Kula NS; Baldessarini RJ; Neumeyer JL
Bioorg Med Chem Lett; 2001 Dec; 11(23):3049-53. PubMed ID: 11714608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
